Catabasis Pharmaceuticals, Inc.
FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY

Last updated:

Abstract:

The invention relates to fatty acid cysteamine conjugates, compositions comprising a fatty acid cysteamine conjugate, and methods for using such conjugates and compositions to treat disease, such as a disease caused by dysregulation of autophagy.

Status:
Application
Type:

Utility

Filling date:

8 Apr 2019

Issue date:

6 Feb 2020